JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krynyckyi, B. R.
Right arrow Articles by Machac, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krynyckyi, B. R.
Right arrow Articles by Machac, J.
Journal of Nuclear Medicine Vol. 44 No. 9 1387-1393
© 2003 by Society of Nuclear Medicine


Clinical Investigations

Factors Affecting Visualization Rates of Internal Mammary Sentinel Nodes During Lymphoscintigraphy

Borys R. Krynyckyi, MD, Hyolim Chun, MD, Hyun Ho Kim, MD, Yasser Eskandar, MD, Chun K. Kim, MD and Josef Machac, MD

Division of Nuclear Medicine, Department of Radiology, Mount Sinai School of Medicine, New York, New York

There is great variation in the reported frequency of internal mammary (IM) sentinel node (SN) visualization. We observed a marked increase in our IM SN detection rate after 2 factors were changed simultaneously: depth of perilesional injection and dose. Methods: A retrospective review of 82 consecutive patients (group 1) was compared with 61 consecutive patients (group 2) after changing the depth of perilesional injections and dose. Both groups had perilesional injections of 99mTc-sulfur colloid followed by intradermal injections at the areolar cutaneous junction. For group 2, activity was increased in all patients scheduled for next-day surgery. Group 2 had perilesional injections on top of, beside, and just below the estimated level of the tumor in an infiltrative manner, versus injections just on top of and beside the tumor as performed for group 1. Results: The rates of IM SN visualization were 4.9% (4/82) for group 1 and 23.0% (14/61) for group 2 (P < 0.003). IM SNs were hotter in group 2 than in group 1. The total number of IM SNs detected per patient was also higher for group 2 than for group 1: 2.1 and 1.2, respectively. In group 2, patients with small breasts had an IM SN visualization rate of 46.2%; those with medium breasts, 21.1%; and those with large breasts, 0% (P < 0.017). In group 2, primary lesions located medially had a higher rate of IM SN visualization than did lesions located laterally: 38.9% (7/18) and 16.2% (6/37), respectively (P = 0.066). Dose was not a statistically significant factor within group 2 or group 1 when comparing IM SN visualization rate for doses above or below the mean or median. Conclusion: Modification of just these 2 factors resulted in a striking change in our IM SN detection rates. The injection depth was the most important factor. Breast size had a marked effect on the probability of detecting IM SNs. This suggests that the variation in detection rates reported in the literature could be at least partly dependent on variations in these factors, among others. Many surgeons do not routinely harvest IM SNs, but information about their presence can potentially alter treatment decisions.

Key Words: internal mammary • sentinel node • lymphoscintigraphy • breast




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
M. S. Yao, B. F. Kurland, A. H. Smith, E. K. Schubert, L. K. Dunnwald, D. R. Byrd, and D. A. Mankoff
Internal Mammary Nodal Chain Drainage Is a Prognostic Indicator in Axillary Node-Positive Breast Cancer
Ann. Surg. Oncol., October 1, 2007; 14(10): 2985 - 2993.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
M. H. K. Leidenius, L. A. Krogerus, T. S. Toivonen, E. A. Leppanen, and K. A. J. von Smitten
The Clinical Value of Parasternal Sentinel Node Biopsy in Breast Cancer
Ann. Surg. Oncol., March 1, 2006; 13(3): 321 - 326.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
B. R. Krynyckyi, C. K. Kim, M. R. Goyenechea, P. T. Chan, Z.-Y. Zhang, and J. Machac
Clinical Breast Lymphoscintigraphy: Optimal Techniques for Performing Studies, Image Atlas, and Analysis of Images
RadioGraphics, January 1, 2004; 24(1): 121 - 145.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.